Serum enzyme changes in patients receiving antituberculosis therapy with rifampicin or p-aminosalicylic acid, plus isoniazid and streptomycin-Reference-Cited by-同舟云学术

Serum enzyme changes in patients receiving antituberculosis therapy with rifampicin or p-aminosalicylic acid, plus isoniazid and streptomycin

Published:1974-06 Issue:2 Volume:55 Page:115-120
ISSN:0041-3879
Container-title:Tubercle
language:en
Short-container-title:Tubercle

Author:

Baron D.N.,Bell Joyce L.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference12 articles.

1. A shortened automated procedure for the determination of alkaline phosphatase;Bell;Journal of Clinical Pathology,1964

2. Considérations sur l'emploie de la rifampicine dans la tuberculose et sur sa tolérance dans l'ensemble des cas traités;Bergamini;Revue de Tuberculose et de Pneumologie,1969

3. Co-operative controlled trial of a standard regimen of streptomycin, PAS and isoniazid and three alternative regimens of chemotherapy in Britain;British Medical Research Council Co-Operative Study;Tubercle,1973

4. A note on the spectrophotometric assay of glutamic oxalacetic transaminase in human blood serum;Karmen;Journal of Clinical Investigation,1955

5. Estimation of plasma phosphatase by determination of hydrolysed phenol with amino-antipyrine;Kind;Journal of Clinical Pathology,1954

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Four months of rifampicin monotherapy for latent tuberculosis infection in children;Clinical and Experimental Pediatrics;2021-10-29

2. Antituberculosis drug-induced hepatotoxicity in children;Pediatric Reports;2011-06-20

3. Rifampicin (Rifampin);Kucers' The Use of Antibiotics Sixth Edition;2010-10-29

4. Subchronic toxicity of human immunodeficiency virus and tuberculosis combination therapies in B6C3F1 mice;TOXICOL SCI;1998

5. Antitubercular drugs;Tuberculosis;1995